These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2553 related items for PubMed ID: 17696573

  • 1. Bipolar II disorder : epidemiology, diagnosis and management.
    Benazzi F.
    CNS Drugs; 2007; 21(9):727-40. PubMed ID: 17696573
    [Abstract] [Full Text] [Related]

  • 2. A prediction rule for diagnosing hypomania.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):317-22. PubMed ID: 19141309
    [Abstract] [Full Text] [Related]

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Mar 17; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 4. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS, Benazzi F, Perugi G, Rihmer Z.
    J Affect Disord; 2005 Apr 17; 85(3):245-58. PubMed ID: 15780694
    [Abstract] [Full Text] [Related]

  • 5. Delineation of the clinical picture of Dysphoric/Mixed Hypomania.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):944-51. PubMed ID: 17391823
    [Abstract] [Full Text] [Related]

  • 6. Challenging DSM-IV criteria for hypomania: diagnosing based on number of no-priority symptoms.
    Benazzi F.
    Eur Psychiatry; 2007 Mar 09; 22(2):99-103. PubMed ID: 17129709
    [Abstract] [Full Text] [Related]

  • 7. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul 09; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 8. Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression).
    Benazzi F, Koukopoulos A, Akiskal HS.
    Eur Psychiatry; 2004 Apr 09; 19(2):85-90. PubMed ID: 15051107
    [Abstract] [Full Text] [Related]

  • 9. Symptoms of depression as possible markers of bipolar II disorder.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May 09; 30(3):471-7. PubMed ID: 16427176
    [Abstract] [Full Text] [Related]

  • 10. Is overactivity the core feature of hypomania in bipolar II disorder?
    Benazzi F.
    Psychopathology; 2007 May 09; 40(1):54-60. PubMed ID: 17065838
    [Abstract] [Full Text] [Related]

  • 11. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD.
    Turk Psikiyatri Derg; 2021 May 09; 32(4):293-295. PubMed ID: 34964106
    [Abstract] [Full Text] [Related]

  • 12. Testing new diagnostic criteria for hypomania.
    Benazzi F.
    Ann Clin Psychiatry; 2007 May 09; 19(2):99-104. PubMed ID: 17612849
    [Abstract] [Full Text] [Related]

  • 13. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):86-93. PubMed ID: 18992784
    [Abstract] [Full Text] [Related]

  • 14.
    Sekhon S, Gupta V.
    ; 2024 01 01. PubMed ID: 32644337
    [Abstract] [Full Text] [Related]

  • 15. What is hypomania? Tetrachoric factor analysis and kernel estimation of DSM-IV hypomanic symptoms.
    Benazzi F.
    J Clin Psychiatry; 2009 Nov 01; 70(11):1514-21. PubMed ID: 19744407
    [Abstract] [Full Text] [Related]

  • 16. Frequency of bipolar spectrum in 111 private practice depression outpatients.
    Benazzi F.
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug 01; 253(4):203-8. PubMed ID: 12910352
    [Abstract] [Full Text] [Related]

  • 17. A tetrachoric factor analysis validation of mixed depression.
    Benazzi F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):186-92. PubMed ID: 17804137
    [Abstract] [Full Text] [Related]

  • 18. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.
    Akiskal HS, Akiskal KK, Lancrenon S, Hantouche EG, Fraud JP, Gury C, Allilaire JF.
    J Affect Disord; 2006 Dec 01; 96(3):197-205. PubMed ID: 16824616
    [Abstract] [Full Text] [Related]

  • 19. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 01; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 20. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.
    Akiskal HS, Bourgeois ML, Angst J, Post R, Möller H, Hirschfeld R.
    J Affect Disord; 2000 Sep 01; 59 Suppl 1():S5-S30. PubMed ID: 11121824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 128.